May 13, 2026
Violet Therapeutics
Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome.
- Round
- Seed
- Amount raised
- $4.8M
- Lead investor
- Dementia Discovery Fund
- Industry
- Health Care
- Headquarters
- Cambridge, United States
- Employees
- 11-50
- Website
- www.violettx.com
- View profile →
Other investors
- Lifespan Vision Ventures
- UTEC - The University of Tokyo Edge Capital Partners
Source: Crunchbase snapshot 2026-05-15